Medivate Partners
Overview
Medivate Partners is a private equity and venture capital firm that focuses investment in biotech/healthcare industry in Asia and North America. The firm is well positioned to capture surging healthcare investment opportunities between Asia and North America, and looks to arbitrage the unique cross border investment advantages. While closing its second fund, Medivate Partners quickly built a reputation for providing inner circle access to top caliber syndicates and successful life science deals in Asia and North America.
Investment Focus
- Clinical-stage biotech companies
- Contract development manufacturing organizations (CDMOs)
- Innovative healthcare solutions
Portfolio Companies
Reach Medivate Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Medivate Partners
What sectors does Medivate Partners invest in?
Medivate Partners invests in Life Sciences, Healthcare Services, Pharmaceuticals, Medical Devices, Medtech and Biotechnology, and is based in Seoul, South Korea. Medivate Partners is listed as a private equity in the ConnectSafely investor database.
What stage does Medivate Partners invest at?
Medivate Partners backs companies at Early Stage, writing cheques of 10M - 50M.
Which regions does Medivate Partners invest in?
Medivate Partners invests across United States and South Korea.
What companies has Medivate Partners invested in?
Medivate Partners's portfolio includes Cognate BioServices and Genopis Inc..
How do I contact Medivate Partners?
Medivate Partners's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
